Assembly Biosciences (ASMB) Change in Cash (2010 - 2026)

Assembly Biosciences' Change in Cash history runs 17 years deep, the most recent figure standing at -$27.3 million for Q1 2026.

• On a quarterly basis, Change in Cash fell 83.04% year-over-year to -$27.3 million in Q1 2026; TTM through Mar 2026 was $7.7 million, a 65.24% increase from a year earlier, with the FY2025 full-year figure at $20.1 million, up 8.66% from the prior year.
• Change in Cash declined to -$27.3 million in Q1 2026 per ASMB's latest filing, from $35.9 million in the prior quarter.
• Across five years, Change in Cash topped out at $35.9 million in Q4 2025 and bottomed at -$27.3 million in Q1 2026.
• The 5-year median for Change in Cash is -$1.1 million (2024), against an average of -$853352.9.
• Biggest YoY gain for Change in Cash was 263.08% in 2025; the steepest drop was 1267.31% in 2025.
• Year by year, Change in Cash stood at -$2.3 million in 2022, then sank by 202.22% to -$6.8 million in 2023, then soared by 245.15% to $9.9 million in 2024, then soared by 263.08% to $35.9 million in 2025, then tumbled by 176.09% to -$27.3 million in 2026.
• Per Business Quant, the three latest ASMB Change in Cash figures stand at -$27.3 million (Q1 2026), $35.9 million (Q4 2025), and -$1.5 million (Q3 2025).